M-Vizion™ Macroscopic Radiographic Study

Description

Study of the patient's subsidence after revision hip arthroplasty by assessing gross stem subsidence in the femoral canal.

Conditions

Revision Hip Arthroplasty

Talk to us

Study Overview

On this page

Study Details

Study overview

Study of the patient's subsidence after revision hip arthroplasty by assessing gross stem subsidence in the femoral canal.

Medacta M-Vizion™ Macroscopic Radiographic Study, Multi-center, Post-Market Outcomes Study

M-Vizion™ Macroscopic Radiographic Study

Condition
Revision Hip Arthroplasty
Intervention / Treatment

-

Contacts and Locations

Chicago

Northwestern Medicine, Chicago, Illinois, United States, 60611

Boston

New England Baptist Hospital, Boston, Massachusetts, United States, 02120

Lebanon

Dartmouth Health, Lebanon, New Hampshire, United States, 03756

Charlotte

OrthoCarolina Research Institute, Inc., Charlotte, North Carolina, United States, 28207

Salt Lake City

University of Utah Department of Orthopaedics, Salt Lake City, Utah, United States, 84108

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Must be able to read, understand, and provide written informed consent on the Institutional Review Board (IRB) approved Informed Consent Form (ICF).
  • * Ability to understand and provide written authorization for use and disclosure of personal health information.
  • * Subjects who are able and willing to comply with the study protocol and follow-up visits.
  • * Patients requiring a revision total hip replacement.
  • * Subjects undergoing revision THA who will receive an M-Vizion femoral component according to the indications for use.
  • * Male and female patients ages 21 - 80 years of age at the time of surgery.
  • * Patients with neuromuscular or neurosensory deficiency, which would limit the ability to assess the performance of the device.
  • * Patients with a systemic or metabolic disorder leading to progressive bone deterioration.
  • * Patients bone stock is compromised by disease or infection, which could possibly prevent adequate support and/or fixation to the prosthesis.
  • * Patients with an active or suspected latent infection in or about the hip joint.
  • * Patients that are incarcerated.

Ages Eligible for Study

21 Years to 80 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Medacta USA,

Study Record Dates

2025-06-01